BridgeBio Pharma (BBIO) PT Raised to $110 at TD Cowen
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $65.71 -5.08%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $110.00 (from $95.00) while maintaining a Buy rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB177 at Citi
- Pepsico (PEP) PT Lowered to $161 at BNP Paribas Exane, 'Expect Renewed Calls for Greater Urgency in NA'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
